您的位置: 首页 > 农业专利 > 详情页

שימוש בתרכובות להכנת תרופות להורדת רמות 6–il במחלה אשר מאופיינת ברמות 6–il גבוהות
专利权人:
RESVERLOGIX CORP.
发明人:
申请号:
IL21519411
公开号:
IL215194A
申请日:
2011.09.18
申请国别(地区):
IL
年份:
2017
代理人:
摘要:
Disclosed are novel compounds that are useful in regulating the expression of interleukin-6 (IL-6) and/or vascular cell adhesion molecule-1 (VCAM-1), and their use in the treatment and/or prevention of cardiovascular and inflammatory diseases and related disease states, such as, for example, atherosclerosis, asthma, arthritis, cancer, multiple sclerosis, psoriasis, and inflammatory bowel diseases, and autoimmune disease(s). Also, disclosed are compositions comprising the novel compounds, as well as methods for their preparation.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充